002773 Chengdu Kanghong Pharmaceutical Group
- 19.17
- +0.28+1.48%
About Chengdu Kanghong Pharmaceutical Group Company
The company was founded in 1996, has advanced R&D centers and standard industrial production bases, and a marketing network all over the country. The company's main business is R&D, production and sales of pharmaceuticals (including biological products, proprietary Chinese medicines, chemicals) and medical devices (mainly ophthalmic medical devices). The main products are: compacipril ophthalmic injections, hepatic relief capsules, Songling Xuemaikang capsules, Qiuoxin capsules, cholestasis capsules, Yiqing capsules, venlafaxine hydrochloride sustained-release tablets, aripiprazole oral solution, mosapride citrate tablets, moxapride citrate tablets, dzopiclone tablets, etc. Corporate honors include “Innovative Drug with the Most Clinical Value”, the 5th “China Industry Award”, and the China Patent Gold Award.
Company Profile
Company Executives
- Name
- Position
- Salary
- zunhong ke
- Chairman, Directors, Nomination Committee Members, Audit Committee Members, Chairman of the Strategy Committee
- 1.32M
- zhirong zhang
- Directors
- --
- xiao ke
- Directors, President, Member of the Strategy Committee
- 2.05M
- jinqun yin
- Directors, VP, Member of the Strategy Committee
- 5.85M
- lin wang
- Directors, Member of the Strategy Committee
- --
- jianrong zhong
- Directors, VP, Head of Internal Audit Department, Member of the Remuneration and Assessment Committee
- 1.43M
- demin zhou
- Independent Directors, Member of the Strategy Committee, Chairman of the Nomination Committee
- 50.00K
- nan xu
- Independent Directors, Chairman of the Audit Committee, Member of the Remuneration and Assessment Committee
- 50.00K
- hongguang deng
- Independent Directors, Nomination Committee Members, Chairman of the Remuneration and Assessment Committee, Audit Committee Member
- 50.00K
- kang deng
- Board Secretary
- 1.38M
- gaolei liu
- Securities Affairs Representative
- --
- wenxian gong
- Chairman of the Supervisory Board, Shareholder Supervisors
- 600.00K
- yanmei cheng
- Auditors
- 199.00K
- jing ni
- VP
- 4.71M
- yanhua xu
- VP
- 3.49M
- jianjun zhong
- VP, Chief Financial Officer
- 3.00M
- yinying yang
- Employee Supervisors
- 490.90K
Analysis
Price Target
No Data
No Data